Catherine Walsh  ·  Health & Science Correspondent

March 2026  ·  5 min read

Dr. James Okafor during a recent presentation on conservative treatment gaps in lumbar disc management.

If your surgeon has recommended a spinal fusion for your L4-L5 or L5-S1 — whether you're dealing with a herniation, sciatica, or degenerative disc disease — there are five questions you should ask before scheduling the procedure.

These aren't trick questions. They're straightforward clinical questions that any surgeon should be able to answer. But in eighteen years of research, Dr. James Okafor — a biomechanics researcher who studies why the conservative path fails — has found that most patients never ask them. And most surgeons never volunteer the answers.

Each question reveals a specific gap in the treatment path you've been on. Together, they paint a picture of a conservative path that was never complete — and a surgical recommendation that may be premature.

Print these. Bring them to your next consultation. You deserve the answers before you sign.

Your surgeon will tell you spinal fusion has a 70-80% success rate. That sounds reassuring. But turn the number around: 20-30% of patients develop what's called Failed Back Surgery Syndrome. The surgery doesn't relieve their pain. Some get worse.

Ask the follow-up: "What are the success rates for a second procedure if the first one fails?"

The data is sobering. Repeat surgery success rates drop dramatically — 50% for the second procedure, 30% for the third, 15% for the fourth. Each additional surgery carries more risk, more scar tissue, more hardware, and lower odds of relief.

Spinal fusion permanently welds two vertebrae together with metal hardware. It eliminates motion at that segment forever. It cannot be undone. That's not a reason to refuse surgery — it's a reason to make absolutely certain every conservative option has been genuinely exhausted first.

Most patients hear "70-80% success rate" and feel reassured. But if you're the one in four or five who ends up in the failure group, there's no undo button. The question isn't whether surgery works — it's whether you've truly exhausted every option before the irreversible one.

Walk through your treatment history with your surgeon. Ibuprofen. Physical therapy. Gabapentin. Epidural injections. Ask specifically: "Which of these addressed the cause of the disc degeneration, not just the pain?"

Dr. Okafor's research has documented a consistent pattern across thousands of cases: every step in the standard conservative path either masks the pain signal or temporarily suppresses inflammation at the local level. Not one of them addresses the chronic inflammatory cascade that's been dehydrating the disc from the inside.

Same structure. Different hydration. Your disc works the same way.

Your disc is approximately 80% water. That water is held in place by molecules called proteoglycans. Chronic inflammation degrades these molecules. When they degrade, the disc can't hold water. It dehydrates. It shrinks. It bulges. The nerve compresses. That compression is your sciatica.

The word "degenerative" on your MRI describes this process — not a permanent verdict. But if no treatment in your history has addressed the inflammatory cascade driving the dehydration, then the conservative path was never complete.

If your surgeon can't point to a single treatment that addressed the upstream cause of your disc degeneration, then the "failure" of conservative treatment isn't really a failure of the approach — it's a failure of the specific treatments you were offered. The path had a gap. The question is whether that gap has been filled.

This is the question that changes the conversation.

Gabapentin modulates the nerve signal. It reduces the brain's ability to hear the pain. Your pain score drops from an 8 to a 5. On paper, that looks like progress. But gabapentin does nothing about the inflammation that's physically compressing the nerve.

Dr. Okafor uses a precise analogy: gabapentin numbs the fire alarm. The alarm is screaming because there's a fire. Muting the alarm doesn't put out the fire. The disc is still inflamed. The dehydration is still progressing. The sciatica nerve is still compressed. The patient just can't feel it as clearly — and can't think as clearly either.

The cognitive side effects are well-documented: fog, memory loss, balance problems, weight gain of 15-30 pounds, reaction time impairment. A recent BMJ study linked long-term gabapentin use to a 29% increased risk of dementia.

If gabapentin lowered your pain score but the sciatica came right back when you stopped taking it — or you stopped taking it because the side effects were worse than the pain — that's not a conservative treatment that "failed." That's a treatment that was never designed to address your actual problem. Your pain score improved. Your disc didn't.

This is the question most surgeons can't answer — because it's not in their training.

The science behind curcumin — turmeric's active compound — is real. Over 20,000 published studies document its anti-inflammatory properties. It suppresses NF-κB activation and downregulates COX-2. The clinical research is substantial and well-established.

But standard curcumin capsules have 2-3% bioavailability. That means 97% of what you swallowed was destroyed by your stomach acid and liver enzymes before it reached your bloodstream. The tiny amount that survived had virtually no chance of reaching an avascular disc buried deep in your lumbar spine.

Three brands. Twelve months. Hundreds of capsules. And your disc didn't receive enough curcumin to make a measurable difference — not because the science was wrong, but because the delivery vehicle was designed to fail.

Liquid compounds held under the tongue bypass this bottleneck entirely. Sublingual absorption delivers compounds through the mucous membranes directly into the bloodstream. No stomach acid. No liver enzymes. No 97% destruction. It's the same delivery principle hospitals use when they need a drug to work at full concentration — they don't hand you a capsule.

If you tried turmeric, saw nothing, and concluded "supplements don't work for my back" — you were right about capsules. You were wrong about the science. The ingredient wasn't the failure. The vehicle was. And nobody told you.

Your surgeon will likely pause on this one.

The body runs inflammation through at least three independent signaling pathways: 5-LOX, NF-κB, and COX. Standard NSAIDs like ibuprofen target one — COX. Most single-ingredient supplements target one. Gabapentin targets none.

Dr. Okafor's analogy: it's like shutting off one circuit breaker in a house with three circuits running. The kitchen goes dark. The basement and the bedroom stay lit. The inflammation continues through the pathways nobody addressed.

Multi-pathway intervention — targeting 5-LOX, NF-κB, and COX simultaneously — produces outcomes that single-pathway intervention does not. The research is clear on this. Devil's Claw inhibits 5-LOX. Curcumin suppresses NF-κB. White willow bark blocks COX. Three switches. Three botanicals. Simultaneous action.

This is the architecture behind a protocol called Lumbar IV — six botanicals targeting three pathways, delivered as a liquid held under the tongue. Built by Marcus Reid, a contractor who spent $14,000 on the standard conservative path before his own surgeon recommended a fusion. He built the product he couldn't find.

If every anti-inflammatory treatment you've received targeted only one pathway out of three, then two-thirds of the inflammatory cascade driving your disc dehydration and your sciatica was never addressed. The conservative path didn't fail. It was never complete.

If your surgeon can't answer all five of these questions — or if the answers reveal that no treatment in your history has addressed the upstream inflammatory cascade, the bioavailability bottleneck, or more than one inflammatory pathway — then the conservative path you were offered before surgery was structurally incomplete.

That doesn't mean surgery is wrong. It means the decision to have surgery may be premature.

Surgery is permanent. It cannot be undone. And "permanent" should be the last option — not the next one.

A year of Lumbar IV costs less than a single epidural injection. And it comes with a 365-day money-back guarantee — if you don't feel the difference within a full year, you receive a complete refund. Empty bottles. No questions.

Surgery will still be there if you need it. It's not going anywhere. But try the conservative path before the irreversible one.